157 related articles for article (PubMed ID: 25497874)
1. Can perfusion MRI predict response to preoperative treatment in rectal cancer?
Martens MH; Subhani S; Heijnen LA; Lambregts DM; Buijsen J; Maas M; Riedl RG; Jeukens CR; Beets GL; Kluza E; Beets-Tan RG
Radiother Oncol; 2015 Feb; 114(2):218-23. PubMed ID: 25497874
[TBL] [Abstract][Full Text] [Related]
2. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
[TBL] [Abstract][Full Text] [Related]
3. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.
Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S
Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958
[TBL] [Abstract][Full Text] [Related]
4. Could perfusion heterogeneity at dynamic contrast-enhanced MRI be used to predict rectal cancer sensitivity to chemoradiotherapy?
Palmisano A; Esposito A; Rancoita PMV; Di Chiara A; Passoni P; Slim N; Campolongo M; Albarello L; Fiorino C; Rosati R; Del Maschio A; De Cobelli F
Clin Radiol; 2018 Oct; 73(10):911.e1-911.e7. PubMed ID: 30029837
[TBL] [Abstract][Full Text] [Related]
5. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
6. Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy.
Monguzzi L; Ippolito D; Bernasconi DP; Trattenero C; Galimberti S; Sironi S
Eur J Radiol; 2013 Feb; 82(2):234-40. PubMed ID: 23122748
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
Tong T; Sun Y; Gollub MJ; Peng W; Cai S; Zhang Z; Gu Y
J Magn Reson Imaging; 2015 Sep; 42(3):673-80. PubMed ID: 25652254
[TBL] [Abstract][Full Text] [Related]
8. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
[TBL] [Abstract][Full Text] [Related]
9. Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer.
Gollub MJ; Tong T; Weiser M; Zheng J; Gonen M; Zakian KL
Eur Radiol; 2017 Apr; 27(4):1605-1612. PubMed ID: 27436029
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
11. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI.
Zou HH; Yu J; Wei Y; Wu JF; Xu Q
J Magn Reson Imaging; 2019 Mar; 49(3):885-893. PubMed ID: 30079601
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival.
Bakke KM; Hole KH; Dueland S; Grøholt KK; Flatmark K; Ree AH; Seierstad T; Redalen KR
Acta Oncol; 2017 Jun; 56(6):813-818. PubMed ID: 28464745
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation.
Intven M; Reerink O; Philippens ME
J Magn Reson Imaging; 2015 Jun; 41(6):1646-53. PubMed ID: 25124320
[TBL] [Abstract][Full Text] [Related]
14. Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer?
Engin G; Sharifov R; Güral Z; Sağam EK; Sağlam S; Balik E; Asoğu O; Yamaner S; Güllüoğu M; Kapran Y; Özel S
Diagn Interv Radiol; 2012; 18(6):574-81. PubMed ID: 22798154
[TBL] [Abstract][Full Text] [Related]
15. Standardized Index of Shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC.
Petrillo A; Fusco R; Petrillo M; Granata V; Sansone M; Avallone A; Delrio P; Pecori B; Tatangelo F; Ciliberto G
Eur Radiol; 2015 Jul; 25(7):1935-45. PubMed ID: 25577525
[TBL] [Abstract][Full Text] [Related]
16. DCE-MRI time-intensity curve visual inspection to assess pathological response after neoadjuvant therapy in locally advanced rectal cancer.
Petrillo A; Fusco R; Petrillo M; Granata V; Bianco F; Di Marzo M; Delrio P; Tatangelo F; Botti G; Pecori B; Avallone A
Jpn J Radiol; 2018 Oct; 36(10):611-621. PubMed ID: 30039258
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted MRI for Early Prediction of Treatment Response on Preoperative Chemoradiotherapy for Patients With Locally Advanced Rectal Cancer: A Feasibility Study.
Jacobs L; Intven M; van Lelyveld N; Philippens M; Burbach M; Seldenrijk K; Los M; Reerink O
Ann Surg; 2016 Mar; 263(3):522-8. PubMed ID: 26106836
[TBL] [Abstract][Full Text] [Related]
18. Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer.
Intven M; Monninkhof EM; Reerink O; Philippens ME
Acta Oncol; 2015 Nov; 54(10):1729-36. PubMed ID: 25914930
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment.
Ciolina M; Caruso D; De Santis D; Zerunian M; Rengo M; Alfieri N; Musio D; De Felice F; Ciardi A; Tombolini V; Laghi A
Radiol Med; 2019 May; 124(5):331-338. PubMed ID: 30560501
[TBL] [Abstract][Full Text] [Related]
20. Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI.
Shi L; Zhang Y; Nie K; Sun X; Niu T; Yue N; Kwong T; Chang P; Chow D; Chen JH; Su MY
Magn Reson Imaging; 2019 Sep; 61():33-40. PubMed ID: 31059768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
